PO-40 PRODIGE: a randomized placebo-controlled trial of long-term thromboprophylaxis using dalteparin low molecular weight heparin (LMWH) in patients with newly diagnosed malignant glioma: updated results
J. Perry, L. Rogers, N. Laperriere, J. Julian, W. Geerts, G. Agnelli, M. Malkin, R. Sawaya, R. Baker, T. Finch, M. LevineVolume:
120
Year:
2007
Language:
english
DOI:
10.1016/s0049-3848(07)70193-7
File:
PDF, 52 KB
english, 2007